Correlation Between Ikena Oncology and Decibel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Decibel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Decibel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ikena Oncology and Decibel Therapeutics, you can compare the effects of market volatilities on Ikena Oncology and Decibel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Decibel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Decibel Therapeutics.

Diversification Opportunities for Ikena Oncology and Decibel Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ikena and Decibel is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Decibel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Therapeutics and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Decibel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Therapeutics has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Decibel Therapeutics go up and down completely randomly.

Pair Corralation between Ikena Oncology and Decibel Therapeutics

Given the investment horizon of 90 days Ikena Oncology is expected to generate 1.36 times more return on investment than Decibel Therapeutics. However, Ikena Oncology is 1.36 times more volatile than Decibel Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Decibel Therapeutics is currently generating about -0.24 per unit of risk. If you would invest  679.00  in Ikena Oncology on August 31, 2024 and sell it today you would lose (506.00) from holding Ikena Oncology or give up 74.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy8.56%
ValuesDaily Returns

Ikena Oncology  vs.  Decibel Therapeutics

 Performance 
       Timeline  
Ikena Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Decibel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Decibel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Decibel Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Ikena Oncology and Decibel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ikena Oncology and Decibel Therapeutics

The main advantage of trading using opposite Ikena Oncology and Decibel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Decibel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Therapeutics will offset losses from the drop in Decibel Therapeutics' long position.
The idea behind Ikena Oncology and Decibel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Directory
Find actively traded commodities issued by global exchanges